Clinical Trial Applications: Filter, Search, and view applications
| # | Protocol No | Study Title | Investigator(s) & Site(s) | |
|---|---|---|---|---|
501.  | 
                ECCT/25/02/02 | HPV vaccine feasibility study Generating local data on HPV vaccination impact and training needs at the level of vaccine implementers – A feasibility study | 
                  Principal Investigator(s) 1. Prof Kenneth Ngure Site(s) in Kenya KEMRI-CCR PHRD( (THIKA) PROJECT  | 
                
                
                   View  | 
              
502.  | 
                ECCT/25/02/03 | NOZE20240219TB “Validation of a Digital Olfaction Based Breathalyzer Device for Non-Invasive Detection of Volatile Biomarkers in Patients with and without Tuberculosis: Case Control Study”. | 
                  Principal Investigator(s) 1. Ibrahim Daud Site(s) in Kenya KEMRI/WRP CRC Kericho  | 
                
                
                   View  | 
              
503.  | 
                ECCT/25/02/04 | Clearance of High-Risk HPV A Randomized, Placebo-Controlled Study to Evaluate Clearance of High-Risk Human Papillomavirus and Safety After Administration of ABI-2280 Vaginal Inserts | 
                  Principal Investigator(s) 1. Jacqueline Mirera Site(s) in Kenya 1. CREA-N Machakos Level 5 Hospital Site (Machakos county)  | 
                
                
                   View  | 
              
504.  | 
                ECCT/25/02/05 | Clearance of High-Risk HPV A Randomized, Placebo-Controlled Study to Evaluate Clearance of High-Risk Human Papillomavirus and Safety After Administration of ABI-2280 Vaginal Inserts | 
                  Principal Investigator(s) 1. Irene Diana Odhiambo Site(s) in Kenya 1. Victoria Biomedical Research Institute, Kisumu County Referral Hospital (Kisumu county)  | 
                
                
                   View  | 
              
505.  | 
                ECCT/25/02/06 | Clearance of High-Risk HPV A Randomized, Placebo-Controlled Study to Evaluate Clearance of High-Risk Human Papillomavirus and Safety After Administration of ABI-2280 Vaginal Inserts | 
                  Principal Investigator(s) 1. Omu Anzala Site(s) in Kenya 1. KAVI-Institute of Clinical Research (KAVI - ICR) (Nairobi City county)  | 
                
                
                   View  | 
              
